Preexisting Cardiovascular Conditions Tied to Severe COVID-19 in Children

THURSDAY, May 19, 2022 (HealthDay News) -- Some previous or preexisting cardiovascular conditions are associated with increased severity of COVID-19 among children, according to a study published online May 17 in JAMA Network Open.
Louis Ehwerhemuepha, Ph.D., from Children's Health of Orange County in California, and colleagues examined associations between previous or preexisting cardiovascular conditions and severity of COVID-19 in pediatric patients. Analysis included 171,416 patients (aged 2 months to 17 years; median age, 8 years) with a laboratory-confirmed diagnosis of COVID-19 or a diagnosis code indicating infection or exposure to severe acute respiratory syndrome coronavirus 2 at 85 health systems (March 1, 2020, to Jan. 31, 2021).
The researchers found that the following cardiovascular conditions were associated with severe COVID-19: cardiac arrest (odds ratio [OR], 9.92), cardiogenic shock (OR, 3.07), heart surgery (OR, 3.04), cardiopulmonary disease (OR, 1.91), heart failure (OR, 1.82), hypotension (OR, 1.57), nontraumatic cerebral hemorrhage (OR, 1.54), pericarditis (OR, 1.50), simple biventricular defects (OR, 1.45), venous embolism and thrombosis (OR, 1.39), other hypertensive disorders (OR, 1.34), complex biventricular defects (OR, 1.33), and essential primary hypertension (OR, 1.22).
"Although the magnitude of the associations found in this study differed considerably across the 26 cardiovascular conditions studied, the results suggest a high overall cardiovascular burden associated with severe COVID-19," the authors write.
One author disclosed financial ties to the medical technology industry.
Related Posts
Findings of IDEA Collaboration Have Influenced Prescribing Patterns
WEDNESDAY, Aug. 9, 2023 (HealthDay News) -- Changes in prescribing patterns for...
CDC Advisers Recommend Pfizer Booster Shot for Children 5 to 11
FRIDAY, May 20, 2022 (HealthDay News) -- A panel of science advisers to the U.S....
Employment at Skilled Nursing Facilities Declined During COVID-19
MONDAY, March 7, 2022 (HealthDay News) -- There were considerable declines in...
A Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- People with one form of the genetic...